Account
News
30.03.2023
PMA Insights: Week 13 SPECIAL EDITION – Worl...

We summarise the World EPA Congress 2023 including plenary sessions on EU HTA, market archetypes, he...

Read more
Insider Insights
09.03.2023
Fimea launches pilot procedure for the evaluation ...

Fimea program aims to standardise the initiation of assessment which are currently different for out...

Read more
Insider Insights
06.03.2023
The Project Orbis initiative

The Project Orbis initiative is an international partnership between medicines regulators in the UK,...

Read more
Insider Insights
06.03.2023
Italy AIFA reports on manufacturer paybacks

Collectively, companies still owe AIFA €370 million of the €2.8 billion that industry has to rep...

Read more
News
17.02.2023
PMA Insights: Week 7

We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...

Read more
Insider Insights
17.02.2023
Spain’s Ministry of Health copies NICE, and ...

Spain will ask pharmaceutical companies to submit their economic evaluation studies to reviewed late...

Read more
Insider Insights
23.01.2023
Germany – European joint assessment at deadlock ...

Germany's BPI and vfa advise that the implementation of the European Health Technology Assessment (E...

Read more
Articles
11.01.2023
What are the 5 Pricing & Market Access trends ...

Our experts provide an overview of the five key trends that could shape the pricing and market acces...

Read more
News
04.01.2023
PMA Insights: Week 1

We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...

Read more
Case Studies
01.01.2023
Development of a precision medicines briefing book

Our client had established a precision medicine working group, but had limited knowledge of the term...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.